HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Everyday function profiles in prodromal stages of MCI: Prospective cohort study.

AbstractINTRODUCTION:
The nature and course of limitations in everyday function in the early clinical stages of cognitive decline is not well known.
METHODS:
We compared complex everyday functional profiles at baseline in 59 community-dwelling older individuals with normal cognitive performance who went on to develop incident mild cognitive impairment (MCI) ("pre-MCI") with 284 older individuals who remained cognitively normal over follow-up.
RESULTS:
The mean number of limitations on complex everyday function at baseline was 3.1 ± 3.0 in the 59 pre-MCI cases and 2.0 ± 2.4 in the 284 normal controls (P = .003). Pre-MCI cases had limitations in traveling, entertaining, remembering appointments, and hobbies compared to normal controls. A progressive increase in mild limitations on complex everyday function preceded the incidence of MCI (mean change: pre-MCI 1.9 ± 3.6 vs normal controls 0.5 ± 2.7, P < .001).
DISCUSSION:
Prodromal stages of MCI are associated with progressive mild limitations in complex activities of daily living.
AuthorsJoe Verghese, Pierfilippo De Sanctis, Emmeline Ayers
JournalAlzheimer's & dementia : the journal of the Alzheimer's Association (Alzheimers Dement) Vol. 19 Issue 2 Pg. 498-506 (02 2023) ISSN: 1552-5279 [Electronic] United States
PMID35472732 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2022 the Alzheimer's Association.
Topics
  • Humans
  • Prospective Studies
  • Activities of Daily Living (psychology)
  • Prodromal Symptoms
  • Cognitive Dysfunction (epidemiology)
  • Cognition
  • Neuropsychological Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: